FDA considering Pfizer booster shots

FDA considering Pfizer booster shots

FILE - A man gets a COVID-19 vaccine at a mass vaccination site at the Natick Mall on Wednesday, Feb. 24, 2021, in Natick, Mass. U.S. experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second dose of the shot, to ensure lasting protection against the coronavirus as the delta variant spreads across the country. An announcement was expected as soon as this week, with doses beginning to be administered widely once the Food and Drug Administration formally approves the vaccines. (Matt Stone/The Boston Herald via AP, Pool)

WASHINGTON (AP) — Government advisers are debating whether to recommend extra doses of the Pfizer vaccine, a key step toward the Biden administration’s plan to dispense COVID-19 booster hots to most Americans. Scientists inside and outside the U.S. government have been divided in recent days over the need for boosters and who should get them. A panel of Food and Drug Administration advisers will vote Friday on the safety and effectiveness of boosters. If the FDA approves the extra doses a separate committee convened by the Centers for Disease Control and Prevention will debate who should get boosters and when.

Photo: FILE – A man gets a COVID-19 vaccine at a mass vaccination site at the Natick Mall on Wednesday, Feb. 24, 2021, in Natick, Mass. (Matt Stone/The Boston Herald via AP, Pool)